跳至主要内容
临床试验/IRCT201109067457N4
IRCT201109067457N4已完成未知

Assessment of treatment efficacy and adverse effects of Microrelin in patient with prostate cancer.

Pooyesh darou company0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Male

入选标准

  • 1- High risk prostate cancer with PSA>20 and/or GS>=8 with extraprostatic extension and unsuitable for surgery.
  • 2- Patients with bone metastases.
  • 3- No history of surgery or radiotherapy for prostate cancer.
  • 4- No history of other malignancy or consumption of other hormonal agents except microrelin.
  • 5- Pelvic lymph node involvement .
  • Exclusion criteria:
  • 1- Surgery or raditherapy for prostate cancer.
  • 2- Microrelin withdrawal
  • 3- Coexistance of other malignancy.

排除标准

  • 未提供

研究者

发起方
Pooyesh darou company

相似试验